Approval · Notice of Compliance 7323 · 2005
ELTROXIN: Notice of Compliance 7323
Issued August 24, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7323
- Date
- August 24, 2005
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Thyroid hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELTROXIN | Not yet assigned | — |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB
- LEVOTHYROXINE SODIUM 300 MCG per TAB